94 related articles for article (PubMed ID: 25047469)
21. Microsatellite GTn-repeat polymorphism in the promoter of heme oxygenase-1 gene is an independent predictor of tumor recurrence in male oral squamous cell carcinoma patients.
Vashist YK; Blessmann M; Trump F; Kalinin V; Kutup A; Schneider C; Gawad K; Kaifi JT; Schmelzle R; Izbicki JR; Yekebas EF
J Oral Pathol Med; 2008 Sep; 37(8):480-4. PubMed ID: 18312299
[TBL] [Abstract][Full Text] [Related]
22. Effects of KRAS mutation and polymorphism on the risk and prognosis of oral squamous cell carcinoma.
Wang WY; Chien YC; Wong YK; Lin YL; Lin JC
Head Neck; 2012 May; 34(5):663-6. PubMed ID: 21688344
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants in AKT1 gene were associated with risk and survival of OSCC in Chinese Han Population.
Wang Y; Lin L; Xu H; Li T; Zhou Y; Dan H; Jiang L; Liao G; Zhou M; Li L; Zeng X; Li J; Chen Q
J Oral Pathol Med; 2015 Jan; 44(1):45-50. PubMed ID: 25060489
[TBL] [Abstract][Full Text] [Related]
24. The mismatch repair gene hPMS1 (human postmeiotic segregation1) is down regulated in oral squamous cell carcinoma.
Wang Y; Zhou X; Song Y; Ji X; Zhang A; Zhang G; Gao Z
Gene; 2013 Jul; 524(1):28-34. PubMed ID: 23608172
[TBL] [Abstract][Full Text] [Related]
25. HMGB1 genetic polymorphisms in oral squamous cell carcinoma and oral lichen planus patients.
Supic G; Kozomara R; Zeljic K; Stanimirovic D; Magic M; Surbatovic M; Jovic N; Magic Z
Oral Dis; 2015 May; 21(4):536-43. PubMed ID: 25639284
[TBL] [Abstract][Full Text] [Related]
26. The prognostic significance of polymorphisms in hMLH1/hMSH2 for colorectal cancer.
Wang Y; Li G; Hu F; Bi H; Wu Z; Zhao X; Li Y; Li S; Li D; Cui B; Dong X; Zhao Y
Med Oncol; 2014 Jun; 31(6):975. PubMed ID: 24793746
[TBL] [Abstract][Full Text] [Related]
27. Single nucleotide polymorphism in esophageal cancer related gene 1: an analysis in resected oral squamous cell carcinoma patients.
Blessmann M; Pohlenz P; Atac A; Kaifi JT; Eulenburg C; Kalinin V; Merkert P; Smeets R; Heiland M; Blake F; Schmelzle R; Izbicki JR
Int J Oral Maxillofac Surg; 2009 Jul; 38(7):779-84. PubMed ID: 19394797
[TBL] [Abstract][Full Text] [Related]
28. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.
He Y; Xu X; Chen H; Wang J; Xiong W; Xu Y; Liu J
Gene; 2013 Jul; 523(2):199-204. PubMed ID: 23587910
[TBL] [Abstract][Full Text] [Related]
29. ECRG1 and FGFR4 single nucleotide polymorphism as predictive factors for nodal metastasis in oral squamous cell carcinoma.
Choi KY; Rho YS; Kwon KH; Chung EJ; Kim JH; Park IS; Lee DJ
Cancer Biomark; 2012-2013; 12(3):115-24. PubMed ID: 23481570
[TBL] [Abstract][Full Text] [Related]
30. Association of VEGF-A genetic polymorphisms with cancer risk and survival in advanced-stage oral squamous cell carcinoma patients.
Supic G; Jovic N; Zeljic K; Kozomara R; Magic Z
Oral Oncol; 2012 Nov; 48(11):1171-7. PubMed ID: 22818823
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of DNA mismatch repair genes in endometrial cancer.
Poplawski T; Sobczuk A; Sarnik J; Pawlowska E; Blasiak J
Exp Oncol; 2015 Mar; 37(1):44-7. PubMed ID: 25804231
[TBL] [Abstract][Full Text] [Related]
32. Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype.
Sengupta S; Chakrabarti S; Roy A; Panda CK; Roychoudhury S
Cancer; 2007 Feb; 109(4):703-12. PubMed ID: 17219447
[TBL] [Abstract][Full Text] [Related]
33. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.
Chiu YW; Tu HF; Wang IK; Wu CH; Chang KW; Liu TY; Kao SY
Oral Oncol; 2010 Apr; 46(4):302-6. PubMed ID: 20219412
[TBL] [Abstract][Full Text] [Related]
34. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking.
Yu JH; Bigler J; Whitton J; Potter JD; Ulrich CM
Am J Gastroenterol; 2006 Jun; 101(6):1313-9. PubMed ID: 16771955
[TBL] [Abstract][Full Text] [Related]
35. Effects of interleukin-18 promoter (C607A and G137C) gene polymorphisms and their association with oral squamous cell carcinoma (OSCC) in northern India.
Singh PK; Ahmad MK; Kumar V; Hussain SR; Gupta R; Jain A; Mahdi AA; Bogra J; Chandra G
Tumour Biol; 2014 Dec; 35(12):12275-84. PubMed ID: 25398690
[TBL] [Abstract][Full Text] [Related]
36. MutSα and MutLα immunoexpression analysis in diagnostic grading of oral epithelial dysplasia and squamous cell carcinoma.
Jessri M; Dalley AJ; Farah CS
Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):74-82. PubMed ID: 25446502
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients.
Shin KH; Park KH; Hong HJ; Kim JM; Oh JE; Choung PH; Min BM
Int J Oncol; 2002 Aug; 21(2):297-302. PubMed ID: 12118324
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas.
Supic G; Kozomara R; Jovic N; Zeljic K; Magic Z
Oral Oncol; 2011 Aug; 47(8):702-8. PubMed ID: 21697000
[TBL] [Abstract][Full Text] [Related]
39. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma.
Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895
[TBL] [Abstract][Full Text] [Related]
40. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]